Effect of exogenous leukemia inhibitory factor on reparative regeneration of the peripheral nerve in mice
Labunets I.1, Demydchuk A.2, Shamalo S.2, Utko N.1, Rodnichenko A.1, Rymar S.1, Chaikovsky Y.1,2, Butenko G.1
1State Institute of Genetic and Regenerative Medicine National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
2O. O. Bogomoletz National Medical University, Kyiv, Ukraine
The role of trophic and growth factors in the regeneration of the damaged peripheral nerve is known. The leukemia inhibitory factor (LIF) exhibits properties not only of the polyfunctional cytokine, but also the neurotrophic factor. Regeneration of the peripheral nerve is impaired during oxidative stress in the area of injury.
The purpose of the work was to investigate the effect of recombinant human LIF (rhLIF) on the efficacy of reparative regeneration of the sciatic nerve.
Materials and methods. Adult male FVB/N mice were divided into the following groups: sham-operated; trauma (neurotomy) of the right sciatic nerve; nerve injury and subcutaneous injection of rhLIF at a dose of 1 μg per animal daily from the third day after the nerve injury. The study was conducted 4 weeks after the injury. At morphometry, the density of nerve fibers in distal nerve segments after impregnation with nitric oxide silver was evaluated. The motor function was evaluated in the “open field” test by the number of crossed squares, and in footprint test by the distance between the extreme toes of the right foot. In the area of muscle injury, the content of malondialdehyde, superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase was estimated.
Results. The total number of nerve fibers in the distal segment of the nerve of mice with trauma and injection of rhLIF is greater (p < 0.05) than in mice with only nerve injury and does not differ from sham-operated animals. Horizontal motor activity in mice with nerve injury is lower (p <0.05) than in sham-operated and cytokine injected mice. The distance between the extreme toes of the sham-operated mice is greater (p < 0.05) than in mice with nerve injury, as well as injuries and injections of rhLIF, but after the injection of cytokine, the rates are higher (p < 0.05) than in the group of mice without it. After the injury, the content of malondialdehyde and catalase activity increases in muscle tissue, while the activity of glutathione reductase decreases (p < 0.05). Under the influence of rhLIF, the parameters change to the values of sham-operated mice, and, in addition, the activity of the glutathione peroxidase is significantly increased.
Conclusions. Injection of rhLIF to mice with a sciatic nerve injury promotes a more complete restoration of the structural organization of the damaged nerve and improves the motor function of the injured limb. At the same time, the balance between the factors of oxidative stress and antioxidant system is improved in the muscle tissue in the area of the nerve injury.
Keywords: leukemia inhibitory factor; sciatic nerve; neural tissue regeneration; antioxidant enzymes; motor functionFull Text PDF
|1. Chaikovsky YuB, Deltsova OI, Gerashchenko SB. Mіzhtkaninnі vzaєmodії periferіynogo nerva v normі ta patologії [Interstitial interactions of peripheral nerve in norm and pathology]. Ivano-frankіvs’k: Lіleya – Ivano-Frankivsk: Lileya-НВ, 2009. 408 p. [In Ukrainian]|
|2. Petrova ES. Primenenie stvolovykh kletok dlya stimulyatsii regeneratsii povrezhdennogo nerva [The use of stem cells to stimulate regeneration of a damaged nerve]. Tsitologiya – Cytology. 2012; 54(7): 525-540. [In Russian]|
|3. Petrova ES. Primenenie stvolovykh kletok dlya stimulyatsii regeneratsii povrezhdennogo nerva [The use of stem cells to stimulate regeneration of a damaged nerve]. Tsitologiya – Cytology. 2012; 54(7): 525-540. [In Russian]|
|4. Tsymbaliuk YuV, Malisheva TA, Rudenko SO, et al. Primenenie stvolovykh kletok dlya stimulyatsii regeneratsii povrezhdennogo nerva [Morphological changes of peripheral nerves after neuroraphy and electrostimulation]. Morfologіya – Morphology. 2013; 7(4): 78-85. [In Russian]|
|5. Vasyliev R, Rodnichenko A, Shamalo S, et al. Effects of neural crest-derived multipotent stem cells on regeneration of an injured peripheral nerve in mice. Neurophysiology. 2015; 47(1): 80-83.
|6. Casey D, Dipollina J, Fornaro M. Effects of enhancing neuritogenesis and peripheral nerve regeneration. Neural Regen Res. 2016; 11(2): 220-221. Available: https:// doi:10.4103/1673-5374.177717.
|7. Madduri S, Gander B. Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration. J Peripheral Nervous System. 2010; 15: 93-103.
|8. Rotshenker Sh. Wallerian degeneration: the innate-immune response to traumatic nerve injury. J Neuroinflam. 2011; 8: 109-114. Available: http:/wwwjneuroinflammation.com/content/8/1/109.
|9. Dubovy P, Jancalek R, Kubek T. Role of inflammation and cytokines in peripheral nerve regeneration. Int Rev Neurobiol. 2013; 108: 173-200.
|10. Strafun SS, Gaiovych VV, Savosko SI. Ul’trastrukturna otsіnka vіdnovlennya travmovanogo sіdnichnogo nerva pri autoplastitsі yogo velikikh defektіv u shchurіv v eksperimentі [Ultrastructural evaluation of recovery of injured sciatic nerve at autografting of it’s large defects in rats: Experimental study]. Ukraїns’kiy neyrokhіrurgіchniy zhurnal – Ukrainian Neurosurgical Journal. 2014; 4: 50-54. [In Ukrainian]
|11. Ostasov P. Houdek Z, Cendelin J, et al. Role of leukemia inhibitory factor in the nervous system and its pathology. Rev Neurosci. 2015; 26(4): 443-59.
|12. Nicola N, Babon J. Leukemia inhibitory factor. Cytokine Growth Factor Rev. 2015; 26: 533-544.
|13. Dowsing B, Romeo R, Morrison W, Dowsing B. Expression Of leukemia inhibitory factor in human nerve following injury. J Neurotrauma. 2001; 18(1): 1279-1287.
|14. Naik A, Tandan S, Dudhgaonkar S, et al. Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats. Eur J Pain. 2006; 10(7): 573-579.
|15. DeFrancesko-Lisowitz A, Lindborg J, Niemi J, et al. The neuroimmunology of degeneration and regeneration in peripheral nervous system. Neuroscience. 2015; 302: 174-203.
|16. Labunets IF, Rymar SYu, Chaikovsky YuB, Butenko GM. Sposіb modelyuvannya stimulyatsії regeneratsії ushkodzhenikh periferichnikh nervіv: patent na korisnu model’ [A method of simulating of stimulation the regeneration of damaged peripheral nerves: utility model patent]. Patent # 114550 (UA): МPК G09B23/28. [In Ukrainian]|
|17. Layton M, Lock P, Metcaff D, et al. Cross-species receptor binding characteristics of human and mouse leukemia inhibitory factor suggest a complex binding interaction. J Biol Chem. 1994; 2690: 17048-17055.|
|18. Kolomytsev AK, Chaikovsky YuB, Tereshchenko TL. Bystryy metod impregnatsii azotnokislym serebrom elementov perifericheskoy nervnoy sistemy, prigodnyy dlya parafinovykh i tselloidinovykh srezov [A rapid method of impregnating by silver nitrate elements of the peripheral nervous system, suitable for paraffin and celloidin sections]. Arkh anat. – Anatomy archive. 1981; 8: 93-96. [In Russian]|
|19. LLabunets IF, Demydchuk AS, Shamalo SM. Sposіb otsіnki v eksperimentі efektivnostі vіdnovlennya rukhovoї funktsії nizhn’oї kіntsіvki pіslya ushkodzhennya periferichnogo nerva: patent na korisnu model’ [The method of evaluation in the experiment of the effectiveness of restoring the motor function of the lower limb after damage to the peripheral nerve: utility model patent]. Patent #113678 (UA): МPК G09В 23/28. [In Ukrainian].|
|20. Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978; 86(1): 271-278.
|21. Muradian Kh, Utko N, Mozzhuknina T, et al. Pair-wise linear and 3D nonlinear relationships between the liver antioxidant enzyme activities and the rate of body oxygen consumption in mice. Free Radic Biol Med. 2002; 33: 1736-1739.
|22. Lakin GF. Biometrics. Higher School, Moscow, 1990. 352 p.
|23. Deverman B, Patterson P. Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination. J Neurosci. 2012; 32(6): 2100-2109.
|24. Johansson C, Momma S, Clake D. Identification of neural stem cell in the adult mammalian central nervous system. Cell. 1999; 96(1): 25-34.
|25. Li Y, Zang D. The neuron regrowth is associated with the proliferation of neural precurcor cells after leukemia inhibitory factor injection following spinal cord injury in mice. PLOS ONE. 2014. Available: https://doi.org/10.1371/journal.pone.0116031.
|26. Curtis R, Scherer S, Somogyi R, et al. Retrograde axonal transport of LIF is increased by peripheral nerve injury: correlation with increased LIF expression in distal nerve. Neuron. 1994; 12: 191-204.
|27. Holtmann B, Weise S, Samsam M, et al. Triple knock-out of CNTF, LIF and CT-1 defines cooperative and distinct roles of these neurotrophic factors for motoneuron maintenance and function. J Neurosci. 2005; 25: 1778-1787.
|28. Razavi S, Mardani M, Kazemi M, et al. Effect of leukemia inhibitory factor on the myelinogenic ability of Schwann-like cells induced from human adipose-derived stem cells. Cell Mol Neurobiol. 2013; 2: 283-290.
|29. Sugiura Sh, Lahav R, Han J, et al. Leukemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur J Neurosci. 2000; 12: 457-466.
|30. Keifer R, Kieseier B, Stoll G, et al. The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol. 2001; 64(2): 109-127.
|31. Xu Jing, Li Zhigui, Xu Pengjuan, et al. Protective effects of leukemia inhibitory factor against oxidative stress during high glucose-induced apoptosis in podocytes. Cell stress and chaperons. 2012; 17: 485-493.
Labunets I, Demydchuk A, Shamalo S, Utko N, Rodnichenko A, Rymar S, Chaikovsky Y, Butenko G. Effect of exogenous leukemia inhibitory factor on reparative regeneration of the peripheral nerve in mice. Cell and Organ Transplantology. 2017; 5(2):182-187. doi:10.22494/cot.v5i2.76